169 related articles for article (PubMed ID: 15885450)
1. Xanthan and galactomannan (from M. scabrella) matrix tablets for oral controlled delivery of theophylline.
Vendruscolo CW; Andreazza IF; Ganter JL; Ferrero C; Bresolin TM
Int J Pharm; 2005 May; 296(1-2):1-11. PubMed ID: 15885450
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of xanthan and highly substituted galactomannan from M. scabrella as a sustained release matrix.
Ughini F; Andreazza IF; Ganter JL; Bresolin TM
Int J Pharm; 2004 Mar; 271(1-2):197-205. PubMed ID: 15129986
[TBL] [Abstract][Full Text] [Related]
3. Effect of hydrophilic natural gums in formulation of oral-controlled release matrix tablets of propranolol hydrochloride.
Rajesh KS; Venkataraju MP; Gowda DV
Pak J Pharm Sci; 2009 Apr; 22(2):211-9. PubMed ID: 19339235
[TBL] [Abstract][Full Text] [Related]
4. Effects of drug solubility, drug loading, and polymer molecular weight on drug release from Polyox tablets.
Kim CJ
Drug Dev Ind Pharm; 1998 Jul; 24(7):645-51. PubMed ID: 9876509
[TBL] [Abstract][Full Text] [Related]
5. The release mechanism of an oral controlled-release delivery system for indomethacin.
Talukdar MM; Rombaut P; Kinget R
Pharm Dev Technol; 1998 Feb; 3(1):1-6. PubMed ID: 9532594
[TBL] [Abstract][Full Text] [Related]
6. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of guar gum in the preparation of sustained-release matrix tablets.
Khullar P; Khar RK; Agarwal SP
Drug Dev Ind Pharm; 1998 Nov; 24(11):1095-9. PubMed ID: 9876566
[TBL] [Abstract][Full Text] [Related]
8. Design, development and in-vitro evaluation of metoprolol tartrate tablets containing xanthan-tragacanth.
Rasul A; Iqbal M; Murtaza G; Waqas MK; Hanif M; Khan SA; Bhatti NS
Acta Pol Pharm; 2010; 67(5):517-22. PubMed ID: 20873420
[TBL] [Abstract][Full Text] [Related]
9. Use of xanthan and its binary blends with synthetic polymers to design controlled release formulations of buccoadhesive nystatin tablets.
Sakeer K; Al-Zein H; Hassan I; Martin GP; Nokhodchi A
Pharm Dev Technol; 2010; 15(4):360-8. PubMed ID: 19772376
[TBL] [Abstract][Full Text] [Related]
10. Effect of channeling agents on the release pattern of theophylline from kollidon SR based matrix tablets.
Ibn Razzak MS; Khan F; Hossain M; Khan MZ; Azad MA; Reza MS
Pak J Pharm Sci; 2009 Jul; 22(3):303-7. PubMed ID: 19553179
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
[TBL] [Abstract][Full Text] [Related]
12. Controlled release of theophylline from inert matrices: effect of channeling material on release rate.
Ghaly ES; Malavé MI; Rivera WJ; Martí A
P R Health Sci J; 1993 Dec; 12(4):255-8. PubMed ID: 8140202
[TBL] [Abstract][Full Text] [Related]
13. Drug release behaviour from methyl methacrylate-starch matrix tablets: effect of polymer moisture content.
Bravo-Osuna I; Ferrero C; Jiménez-Castellanos MR
Eur J Pharm Biopharm; 2008 May; 69(1):285-93. PubMed ID: 17997292
[TBL] [Abstract][Full Text] [Related]
14. Use of hydrophilic natural gums in formulation of sustained-release matrix tablets of tramadol hydrochloride.
Varshosaz J; Tavakoli N; Kheirolahi F
AAPS PharmSciTech; 2006 Mar; 7(1):E24. PubMed ID: 16584155
[TBL] [Abstract][Full Text] [Related]
15. Zero-order release of theophylline from a core-in-cup tablet in sequenced simulated gastric and intestinal fluid.
Danckwerts MP; van der Watt JG; Moodley I
Drug Dev Ind Pharm; 1998 Feb; 24(2):163-7. PubMed ID: 15605446
[TBL] [Abstract][Full Text] [Related]
16. Guar gum as a carrier for colon specific delivery; influence of metronidazole and tinidazole on in vitro release of albendazole from guar gum matrix tablets.
Krishnaiah YS; Seetha Devi A; Nageswara Rao L; Bhaskar Reddy PR; Karthikeyan RS; Satyanarayana V
J Pharm Pharm Sci; 2001; 4(3):235-43. PubMed ID: 11737989
[TBL] [Abstract][Full Text] [Related]
17. Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets.
Ceballos A; Cirri M; Maestrelli F; Corti G; Mura P
Farmaco; 2005; 60(11-12):913-8. PubMed ID: 16129436
[TBL] [Abstract][Full Text] [Related]
18. A new approach combining different MRI methods to provide detailed view on swelling dynamics of xanthan tablets influencing drug release at different pH and ionic strength.
Mikac U; Sepe A; Kristl J; Baumgartner S
J Control Release; 2010 Aug; 145(3):247-56. PubMed ID: 20417675
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of chlorpheniramine maleate release from hydrophilic swellable polymer systems.
Melendez M; Ghaly ES
P R Health Sci J; 1997 Sep; 16(3):259-63. PubMed ID: 9431564
[TBL] [Abstract][Full Text] [Related]
20. In vitro dissolution kinetic study of theophylline from hydrophilic and hydrophobic matrices.
Maswadeh HM; Semreen MH; Abdulhalim AA
Acta Pol Pharm; 2006; 63(1):63-7. PubMed ID: 17515331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
